JP2013505940A5 - - Google Patents

Download PDF

Info

Publication number
JP2013505940A5
JP2013505940A5 JP2012531020A JP2012531020A JP2013505940A5 JP 2013505940 A5 JP2013505940 A5 JP 2013505940A5 JP 2012531020 A JP2012531020 A JP 2012531020A JP 2012531020 A JP2012531020 A JP 2012531020A JP 2013505940 A5 JP2013505940 A5 JP 2013505940A5
Authority
JP
Japan
Prior art keywords
chloro
methyl
administered
combination
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012531020A
Other languages
English (en)
Japanese (ja)
Other versions
JP5890310B2 (ja
JP2013505940A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/049952 external-priority patent/WO2011038085A1/en
Publication of JP2013505940A publication Critical patent/JP2013505940A/ja
Publication of JP2013505940A5 publication Critical patent/JP2013505940A5/ja
Application granted granted Critical
Publication of JP5890310B2 publication Critical patent/JP5890310B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012531020A 2009-09-23 2010-09-23 組合せ Expired - Fee Related JP5890310B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24502709P 2009-09-23 2009-09-23
US61/245,027 2009-09-23
PCT/US2010/049952 WO2011038085A1 (en) 2009-09-23 2010-09-23 Combination

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015246841A Division JP6148320B2 (ja) 2009-09-23 2015-12-18 組合せ

Publications (3)

Publication Number Publication Date
JP2013505940A JP2013505940A (ja) 2013-02-21
JP2013505940A5 true JP2013505940A5 (enExample) 2013-11-14
JP5890310B2 JP5890310B2 (ja) 2016-03-22

Family

ID=43796199

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012531020A Expired - Fee Related JP5890310B2 (ja) 2009-09-23 2010-09-23 組合せ
JP2015246841A Expired - Fee Related JP6148320B2 (ja) 2009-09-23 2015-12-18 組合せ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015246841A Expired - Fee Related JP6148320B2 (ja) 2009-09-23 2015-12-18 組合せ

Country Status (15)

Country Link
US (4) US20120283278A1 (enExample)
EP (1) EP2480085B1 (enExample)
JP (2) JP5890310B2 (enExample)
KR (1) KR101739158B1 (enExample)
CN (1) CN102762098B (enExample)
AU (1) AU2010298280B2 (enExample)
BR (1) BR112012006485A2 (enExample)
CA (1) CA2775125C (enExample)
EA (2) EA201270453A1 (enExample)
ES (1) ES2527831T3 (enExample)
IL (1) IL218801A (enExample)
MX (1) MX2012003547A (enExample)
SG (1) SG179144A1 (enExample)
WO (1) WO2011038085A1 (enExample)
ZA (1) ZA201201940B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI505828B (zh) 2010-12-20 2015-11-01 葛蘭素史克智慧財產(第二)有限公司 新穎醫藥組成物
EP2913048A1 (en) 2014-02-27 2015-09-02 ratiopharm GmbH Pharmaceutical composition comprising trametinib
US20230172936A1 (en) * 2020-05-11 2023-06-08 Cleave Therapeutics, Inc. VCP/p97 INHIBITOR FOR THE TREATMENT OF CANCER

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7378423B2 (en) * 2004-06-11 2008-05-27 Japan Tobacco Inc. Pyrimidine compound and medical use thereof
DE602005004286T2 (de) * 2004-06-11 2009-01-02 Japan Tobacco Inc. 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyridoä2,3-düpyrimidinderivate und verwandte verbindungen zur behandlung von krebs
JP3821154B1 (ja) * 2005-03-16 2006-09-13 いすゞ自動車株式会社 排気ガス浄化方法及び排気ガス浄化システム
UY30892A1 (es) * 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt

Similar Documents

Publication Publication Date Title
JP2013509429A5 (enExample)
JP2016539156A5 (enExample)
JP2016536286A5 (enExample)
MX2015011896A (es) Formulacion de liberacion sostenida de mosapride que proporciona efectos farmacologicos y clinicos con administracion una vez al dia.
JP2012512907A5 (enExample)
JP2013507415A5 (enExample)
JP2014505107A5 (enExample)
JP2013510123A5 (enExample)
JP2012193216A5 (enExample)
JP2016506935A5 (enExample)
JP2012525393A5 (enExample)
JP2014521735A5 (enExample)
JP2014528901A5 (enExample)
JP2011510080A5 (enExample)
JP2011137020A5 (enExample)
JP2011507896A5 (enExample)
JP2014503593A5 (enExample)
HRP20120918T1 (hr) Aminopirazolski spoj
NZ596739A (en) Methods of treating proliferative diseases
JP2014534269A5 (enExample)
JP2008535785A5 (enExample)
JP6014142B2 (ja) N−ヒドロキシ−4−{2−[3−(n,n−ジメチルアミノメチル)ベンゾフラン−2−イルカルボニルアミノ]エトキシ}ベンズアミドの投与に関するスキーム
JP2013505939A5 (enExample)
JP2008517913A5 (enExample)
JP2013505940A5 (enExample)